Revisiting the structure of the Yale Global Tic Severity Scale (YGTSS) in a sample of Chinese children with tic disorders.
Wen F, Gu Y, Yan J, Liu J, Wang F, Yu L, Li Y, Cui Y.
BMC Psychiatry. 2021 Aug 9;21(1):394. doi: 10.1186/s12888-021-03399-5.
PMID:34372795
Tetrahydrocannabinol and Cannabidiol in Tourette Syndrome.
Mosley PE, Webb L, Suraev A, Hingston L, Turnbull T, Foster K, Ballard E, Gomes L, Mohan A, Sachdev PS, Kevin R, Gordon R, Benson M, McGregor IS.
NEJM Evid. 2023 Sep;2(9):EVIDoa2300012. doi: 10.1056/EVIDoa2300012. Epub 2023 Jun 7.
PMID:38320199
Potential impact of COVID-19 on ongoing clinical trials: a simulation study with the neurological Yale Global Tic Severity Scale based on the CANNA-TICS study.
Neurology. 2018 May 8;90(19):e1711-e1719. doi: 10.1212/WNL.0000000000005474. Epub 2018 Apr 13.
PMID:29653992
Is the Yale Global Tic Severity Scale a valid tool for parent-reported assessment in the paediatric population? A prospective observational study in Taiwan.
Ho CS, Huang JY, Yang CH, Lin YJ, Huang MY, Su YC.
BMJ Open. 2020 Aug 20;10(8):e034634. doi: 10.1136/bmjopen-2019-034634.
PMID:32819930
The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity.